Form 4 for ZVRA ZEVRA THERAPEUTICS, INC.
Accepted 2023-01-13 00:00:00 ET · period of report 2023-01-13 · accession 0001437749-23-001059 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-01-13 | 2023-01-13 | ZVRA | Pascoe Richard W | CEO, Dir | P - Purchase | $5.44 | +9,500 | 20.0K | +91% | +$51.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-01-13 | P | A | 9,500 | $5.44 | 19,973 | D | — | — |